173 related articles for article (PubMed ID: 23859303)
1. The efficacy and safety of fixed-dose combination of amlodipine/benazepril in Chinese essential hypertensive patients not adequately controlled with benazepril monotherapy: a multicenter, randomized, double-blind, double-dummy, parallel-group clinical trial.
Yan P; Fan W;
Clin Exp Hypertens; 2014; 36(4):268-74. PubMed ID: 23859303
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
[TBL] [Abstract][Full Text] [Related]
3. An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in chinese patients with mild to moderate hypertension.
Ueng KC; Lin LC; Voon WC; Lin MC; Liu YB; Su HM; Chang PY; Lin TH; Chen WL; Wu CC; Lai WT; Lin CS
Blood Press Suppl; 2008 Jun; 1():24-31. PubMed ID: 18705532
[TBL] [Abstract][Full Text] [Related]
4. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
Chrysant SG; Bakris GL
Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
[TBL] [Abstract][Full Text] [Related]
5. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
6. The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy.
Chrysant SG; Sugimoto DH; Lefkowitz M; Salko T; Khan M; Arora V; Shi V
Blood Press Suppl; 2007 Mar; 1():10-7. PubMed ID: 17566314
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.
Chrysant SG
Drugs R D; 2012 Jun; 12(2):57-64. PubMed ID: 22571394
[TBL] [Abstract][Full Text] [Related]
9. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
[TBL] [Abstract][Full Text] [Related]
12. Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.
Fogari R; Preti P; Lazzari P; Corradi L; Zoppi A; Fogari E; Mugellini A
Eur J Clin Pharmacol; 2003 Aug; 59(4):271-5. PubMed ID: 12830340
[TBL] [Abstract][Full Text] [Related]
13. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
[TBL] [Abstract][Full Text] [Related]
14. Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo.
Kuschnir E; Acuña E; Sevilla D; Vasquez J; Bendersky M; Resk J; Glazer R
Clin Ther; 1996; 18(6):1213-24. PubMed ID: 9001838
[TBL] [Abstract][Full Text] [Related]
15. Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone.
Pool J; Kaihlanen P; Lewis G; Ginsberg D; Oparil S; Glazer R; Messerli FH
J Hum Hypertens; 2001 Jul; 15(7):495-8. PubMed ID: 11464260
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy.
Schunkert H; Glazer RD; Wernsing M; Yen J; Macarie CE; Vintila MM; Romanova J
Curr Med Res Opin; 2009 Nov; 25(11):2655-62. PubMed ID: 19751115
[TBL] [Abstract][Full Text] [Related]
17. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone.
Fogari R; Corea L; Cardoni O; Cosmi F; Porcellati C; Innocenti P; Provvidenza M; Timio M; Bentivoglio M; Bertocchi F; Zoppi A
J Cardiovasc Pharmacol; 1997 Oct; 30(4):497-503. PubMed ID: 9335410
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
Messerli FH; Oparil S; Feng Z
Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
